Insights Into Treatment Paradigms in Classical Hodgkin Lymphoma (cHL)

Perspectives on existing and emerging treatments for cHL in the first line along with the factors that guide treatment choices

National – May 9, 2024
Purchase Report

Faculty Chair

Sarah Rutherford, MD

Weill Cornell Medicine in New York, NY, USA

More Information

  • Virtual series
  • National

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • First-Line Treatment of cHL

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and in-depth moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.